Related Experiment Video
Updated: May 9, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018
Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it
Francisco C Carnevale1,2, Alberto A Antunes3
1Interventional Radiology Unit, University of Sao Paulo Medical School, Av. Dr. Enéas de Carvalho Aguiar, 255, São Paulo, SP, 05403-001, Brazil. fcarnevale@uol.com.br.
Prostatic artery embolization (PAE) offers a safe alternative to surgery for benign prostatic hyperplasia (BPH). This minimally invasive procedure effectively reduces prostate size and improves symptoms without sexual side effects.
Area of Science:
- Interventional Radiology
- Urology
- Vascular Medicine
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Surgical treatments for BPH can lead to significant side effects.
- Prostatic artery embolization (PAE) is an emerging minimally invasive alternative.
Purpose of the Study:
- To evaluate the efficacy and safety of PAE for BPH treatment.
- To identify key factors for successful patient selection and procedural technique.
- To assess the impact of PAE on prostate volume, symptoms, and quality of life.
Main Methods:
- PAE involves embolizing the arteries supplying the prostate.
- Patient selection relies on urodynamic evaluation and MRI.
- Use of small-diameter hydrophilic microcatheters is crucial.
- Technical challenges include vessel tortuosity and anatomical variations.
Main Results:
- PAE demonstrated safe treatment with low complication rates.
- Significant reduction in prostate volume and improvement in clinical symptoms were observed.
- Patients experienced enhanced quality of life without urinary incontinence or sexual dysfunction.
- Multidisciplinary collaboration is vital for optimal outcomes.
Conclusions:
- PAE is a safe and effective treatment option for BPH.
- Careful patient selection and refined techniques are essential for success.
- PAE offers significant symptom relief and quality of life improvement for BPH patients.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

